Pivot Medical, Inc.: Series C $32M

Posted in I - Series C, Q - 4Q11, R - WEST, X - Device (Orthopedic), XX - CA

Pivot Medical (Sunnyvale, CA) a clinical-stage device company focused on minimally invasive hip restoration technologies, closed a $32M Series C financing. Participants include Adams Street Partners, Delphi Ventures, Montreux Equity Partners and Ivy Capital Partners.

Benvenue Medical, Inc.: Series C $35.5M

Posted in I - Series C, Q - 2Q11, R - WEST, X - Device (Orthopedic), X - Device (Spine), XX - CA

Benvenue Medical (Mountain View, CA) a commercial stage medical device company focused on minimally invasive solutions of vertebral compression fractures, closed a $35.5M Series C financing. Participants include Domain Associates, Technology Partners, Versant Ventures and DeNovo Ventures.

OrthoSensor, Inc.: Series B $21M

Posted in I - Series B, Q - 1Q11, R - SOUTH EAST, X - Device (Monitoring), X - Device (Orthopedic), XX - FL

OrthoSensor (Sunrise, FL) a development-stage medical device company focused on remote monitoring of orthopedic implants, closed a $21M Series B financing. Participants include Ziegler Meditech Equity Partners.

Core Essence Orthopaedics, Inc.: Series B $11.5

Posted in I - Series B, Q - 1Q11, R - NORTH EAST, X - Device (Orthopedic), XX - PA

Core Essence Orthopaedics (Fort Washington, PA) a commercial-stage medical device company focused on MIS arthroscopic and endoscopic procedures involving soft tissue and skeletal repair, closed a $11.5M Series B financing. Participants include Baird Venture Partners, NewSpring Health Capital and Robin Hood Ventures.

Small Bone Innovations, Inc.: Series F $15M

Posted in I - Series F, Q - 4Q10, R - NORTH EAST, X - Device (Fixation), X - Device (Orthopedic), XX - PA

Small Bone Innovations (Morrisville, PA) a commercial-stage a small bone and joint device company focused on arthroplasty, fixation, trauma and biologic solutions, closed a $15M Series F financing. Participants have included 3i Group, NGN Capital, Trevi Health Ventures, Viscogliosi Brothers, Vollin Holdings and The Family Office Co.

Curexo Technology Corp.: Series C $13.2M

Posted in I - Series C, Q - 2Q10, R - INTERNATIONAL, X - Device (Orthopedic)

Curexo Technology (Korea) a commercial-stage medical device company focused on robotic surgical systems for joint replacement, closed a $13.2M Series C financing. Participants were not identified.

Implanet, SA: Series D $10.1M

Posted in I - Series D, Q - 2Q10, R - INTERNATIONAL, X - Device (Orthopedic), X - Device (Spine)

Implanet (France) a commercial-stage developer of surgical implants for orthopedic and spine surgery, closed a $10.1M Series D financing. Participants include CM-CIC Private Equity, Edmond de Rothschild Investment Partners, Wellington Partners Venture Capital and Seventures Partners.

OrthAlign, Inc.: Series A $5.2M

Posted in I - Series A, Q - 1Q10, R - WEST, X - Device (Orthopedic), XX - CA

OrthAlign (Irvine, CA) a commercial-stage medical device company focused on tibial alignment in total knee arthroplasty, closed a $5.2M Series A financing. Participants include California Technology Ventures, Okapi Venture Capital and Research Corporation Technologies.

ConforMIS, Inc.: Series D $50M

Posted in I - Series D, Q - 3Q09, R - NORTH WEST, X - Device (Orthopedic), XX - MA

ConforMIS (Burlington, MA) a commercial-stage medical device company focused on personalized resurfacing implants, osteoarthritis treatment and joint damage, closed a $50M Series D financing. Participants include Aeris Capital and previous investors.

Active Implants Corp.: Series C $10M

Posted in I - Series C, Q - 2Q09, R - SOUTH EAST, X - Device (Orthopedic), XX - TN

Active Implants (Memphis, TN) a development-stage company focused on medical grade polycarbonate urethane for hip and knee orthopedic implants, closed a $10M Series C financing. Participants in the round were not identified.

Orthopaedic Synergy, Inc.: Series A $4.8M

Posted in I - Series A, Q - 1Q09, R - NORTH EAST, X - Device (Orthopedic), XX - MA

Orthopaedic Synergy (Raynham, MA) a reorganized holding company comprised of Omni Life Science and Enztec focused on developing devices for the orthopaedic market, closed a $4.8M Series A financing. Participants include Pioneer Capital Partners and Birnie Capital Partners.

Core Essence Orthopaedics: Series A $5M

Posted in I - Series A, Q - 3Q08, R - NORTH EAST, X - Device (Orthopedic)

Core Essence Orthopaedics (Yardley, PA) medical device company focused on soft tissue and skeletal repair, closed a $5M financing. Participants include NewSpring Capital.

OrthoHelix Surgical Devices, Inc.: Series C $7.3M

Posted in I - Series C, Q - 2Q08, R - MID WEST, X - Device (Orthopedic)

OrthoHelix Surgical Devices (Akron, Ohio) developer of medical devices for use in hand and foot reconstructive surgery, closed a $7.3M Series C financing. Participants include River Cities Capital Funds and Mutual Capital Partners.

« Previous Entries

to top of page...